MyFinsight
Home
Blog
About
ILet
$12,651K
(-5.69%↓ Y/Y)
Single Use Products
$7,762K
(48.41%↑ Y/Y)
Single Use Products
$11,379K
(159.26%↑ Y/Y)
ILet
$221K
(7.80%↑ Y/Y)
Comprehensive loss
-$23,697K
(-39.72%↓ Y/Y)
Interest income
$2,177K
(-27.55%↓ Y/Y)
Durable Medical
Equipment Channel
$20,413K
(9.49%↑ Y/Y)
Pharmacy Benefit Plan
Channel
$11,600K
(152.50%↑ Y/Y)
Net loss
-$23,403K
(-38.73%↓ Y/Y)
Unrealized loss on
short-term and long-term...
-$294K
(-223.08%↓ Y/Y)
Total other income
(expense), net
$2,175K
(-27.57%↓ Y/Y)
Net sales
$32,013K
(37.76%↑ Y/Y)
Other expense
-$2K
(0.00%↑ Y/Y)
Loss from operations
-$25,578K
(-28.71%↓ Y/Y)
Gross profit
$18,902K
(51.18%↑ Y/Y)
Cost of sales
$13,111K
(22.13%↑ Y/Y)
Total operating
expenses
$44,480K
(37.39%↑ Y/Y)
Sales and marketing
$24,640K
(57.72%↑ Y/Y)
Research and development
$10,240K
(15.41%↑ Y/Y)
General and
administrative
$9,600K
(21.84%↑ Y/Y)
Back
Back
Income Statement
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)
source: myfinsight.com